Epigenetics: Tools and technologies

Drug Discovery Today: Technologies

Volumn 7, Issue 1, 2010, Pages

  Janzen, William P ^a   Wigle, Tim J ^a   Jin, Jian ^a   Frye, Stephen V ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIX 01294; CHETOCIN; DNA; ENZYME INHIBITOR; HISTONE; HISTONE DEACETYLASE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE LYSINE METHYLTRANSFERASE G 9A; MYCOTOXIN; RNA; UNC 0321; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SPECIFICITY; CHROMATIN; DRUG TARGETING; EPIGENETICS; GENOME; HISTONE CODE; HUMAN; METHYLATION; NUCLEOSOME; PROTEIN MODIFICATION; STRUCTURE ACTIVITY RELATION;

EID: 78649909095     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.07.004     Document Type: Review

References (79)

1. S.L. Berger An operational definition of epigenetics Genes Dev. 23 2009 781 783
2. B.E. Bernstein The mammalian epigenome Cell 128 2007 669 681
3. K.A. Gelato, and W. Fischle Role of histone modifications in defining chromatin structure and function Biol. Chem. 389 2008 353 363
4. A.J. Ruthenburg Multivalent engagement of chromatin modifications by linked binding modules Nat. Rev. Mol. Cell Biol. 8 2007 983 994
5. R. Marmorstein, and R.C. Trievel Histone modifying enzymes: structures, mechanisms, and specificities Biochim. Biophys. Acta 1789 2009 58 68
6. B.T. Seet Reading protein modifications with interaction domains Nat. Rev. Mol. Cell Biol. 7 2006 473 483
7. M. Esteller Epigenetics in cancer N. Engl. J. Med. 358 2008 1148 1159
8. P.A. Marks Histone deacetylase inhibitors Adv. Cancer Res. 91 2004 137 168
9. A. Norvell, and S.B. McMahon Rise of the Rival Science 327 2010 964 965
10. M. Haberland The many roles of histone deacetylases in development and physiology: implications for disease and therapy Nat. Rev. Genet. 10 2009 32 42
11. S. Rea Regulation of chromatin structure by site-specific histone H3 methyltransferases Nature 406 2000 593 599
12. C. Martin, and Y. Zhang The diverse functions of histone lysine methylation Nat. Rev. Mol. Cell Biol. 6 2005 838 849
13. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
14. R.A. Copeland Protein methyltransferases as a target class for drug discovery Nat. Rev. Drug Discov. 8 2009 724 732
15. C.K. Fog Chromatin-modifying proteins in cancer APMIS 115 2007 1060 1089
16. S.C. Dillon The SET-domain protein superfamily: protein lysine methyltransferases Genome Biol. 6 2005 227
17. B.C. Smith, and J.M. Denu Chemical mechanisms of histone lysine and arginine modifications Biochim. Biophys. Acta 1789 2009 45 57
18. M.A. Adams-Cioaba, and J. Min Structure and function of histone methylation binding proteins Biochem. Cell Biol. 87 2009 93 105
19. P. Trojer L3MBTL1, a histone-methylation-dependent chromatin lock Cell 129 2007 915 928
20. P. Trojer, and D. Reinberg Beyond histone methyl-lysine binding: how malignant brain tumor (MBT) protein L3MBTL1 impacts chromatin structure Cell Cycle 7 2008 578 585
21. J.R. Horton Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases Nat. Struct. Mol. Biol. 17 2010 38 43
22. Y. Shi Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953
23. S.C. Trewick Methylation: lost in hydroxylation? EMBO Rep. 6 2005 315 320
24. R.K. McGinty Structure-activity analysis of semisynthetic nucleosomes: mechanistic insights into the stimulation of Dot1L by ubiquitylated histone H2B ACS Chem. Biol. 4 2009 958 968
25. D. Cheng Small molecule regulators of protein arginine methyltransferases J. Biol. Chem. 279 2004 23892 23899
26. S. Kubicek Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase Mol. Cell 25 2007 473 481
27. A.M. Quinn A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors Mol. BioSyst. 2010 10.1039/B921912A
28. T.J. Wigle Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis Chem. Biol. 17 2010 695 704
29. H. Gowher Avidin plate assay system for enzymatic characterization of a histone lysine methyltransferase Anal. Biochem. 342 2005 287 291
30. A. Dhayalan A continuous protein methyltransferase (G9a) assay for enzyme activity measurement and inhibitor screening J. Biomol. Screen. 14 2009 1129 1133
31. E. Collazo A coupled fluorescent assay for histone methyltransferases Anal. Biochem. 342 2005 86 92
32. C.L. Hendricks An enzyme-coupled colorimetric assay for S-adenosylmethionine-dependent methyltransferases Anal. Biochem. 326 2004 100 105
33. K.M. Dorgan An enzyme-coupled continuous spectrophotometric assay for S-adenosylmethionine-dependent methyltransferases Anal. Biochem. 350 2006 249 255
34. J.M. Lizcano A spectrophotometric method for determining the oxidative deamination of methylamine by the amine oxidases Anal. Biochem. 286 2000 75 79
35. M. Sakurai A miniaturized screen for inhibitors of Jumonji histone demethylases Mol. Biosyst. 6 2010 357 364
36. F. Forneris Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process FEBS Lett. 579 2005 2203 2207
37. Y. Huang Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes Proc. Natl. Acad. Sci. U. S. A. 104 2007 8023 8028
38. A.L. Garske Combinatorial profiling of chromatin binding modules reveals multisite discrimination Nat. Chem. Biol. 6 2010 283 290
39. S.A. Jacobs Assays for the determination of structure and dynamics of the interaction of the chromodomain with histone peptides Methods Enzymol. 376 2004 131 148
40. J. Min L3MBTL1 recognition of mono- and dimethylated histones Nat. Struct. Mol. Biol. 14 2007 1229 1230
41. H. Li Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger Mol. Cell 28 2007 677 691
42. C.M. Santiveri The malignant brain tumor repeats of human SCML2 bind to peptides containing monomethylated lysine J. Mol. Biol. 382 2008 1107 1112
43. T.J. Wigle Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins J. Biomol. Screen. 15 2010 62 71
44. A.M. Quinn A homogeneous method for investigation of methylation- dependent protein-protein interactions in epigenetics Nucleic Acids Res. 38 2010 e11
45. A. Spannhoff Cancer treatment of the future: inhibitors of histone methyltransferases Int. J. Biochem. Cell Biol. 41 2009 4 11
46. A. Spannhoff The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors ChemMedChem 4 2009 1568 1582
47. Y. Li Role of the histone H3 Lysine 4 methyltransferase, SET7/9, in the regulation of NF-{kappa}B-dependent inflammatory genes: relevance to diabetes and inflammation J. Biol. Chem. 283 2008 26771 26781
48. I. Maze Essential role of the histone methyltransferase G9a in cocaine-induced plasticity Science 327 2010 213 216
49. A. Schaefer Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex Neuron 64 2009 678 691
50. K.M. McGarvey Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state Cancer Res. 66 2006 3541 3549
51. Y. Kondo Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells PLoS One 3 2008 e2037
52. J. Huang G9A and GLP methylate lysine 373 in the tumor suppressor p53 J. Biol. Chem. 285 2010 9636
53. P.A. Cole Chemical probes for histone-modifying enzymes Nat. Chem. Biol. 4 2008 590 597
54. D. Greiner Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9 Nat. Chem. Biol. 1 2005 143 145
55. Y. Chang Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases J. Mol. Biol. 400 2010 1 7
56. F. Liu Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy- quinazolines J. Med. Chem. 9 2010 5844 5857
57. F. Liu Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a J. Med. Chem. 52 2009 7950 7953
58. For the latest unpublished progress in this area, see: http://www.thesgc.org/chemical-probes/UNC0638/#overview
59. Y. Chang Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 Nat. Struct. Mol. Biol. 16 2009 312 317
60. S.V. Frye The art of the chemical probe Nat. Chem. Biol. 6 2010 159 161
61. J.A. Simon, and C.A. Lange Roles of the EZH2 histone methyltransferase in cancer epigenetics Mutat. Res. 647 2008 21 29
62. S.Y. Roth Histone acetyltransferases Annu. Rev. Biochem. 70 2001 81 120
63. R. Marmorstein, and S.Y. Roth Histone acetyltransferases: function, structure, and catalysis Curr. Opin. Genet. Dev. 11 2001 155 161
64. P.A. Marks Histone deacetylases Curr. Opin. Pharmacol. 3 2003 344 351
65. P. Marks, and R. Breslow Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug Nat. Biotechnol. 25 2007 84 90
66. S. Müller, and H. Krämer Inhibitors of HDACs-effective drugs against cancer? Current Cancer Drug Targets 10 2010 210 228
67. J.E. Bolden Anticancer activities of histone deacetylase inhibitors Nat. Rev. Drug. Discov. 5 2006 769 784
68. P. Gallinari HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics Cell Res. 17 2007 195 211
69. C.M. Grozinger Three proteins define a class of human histone deacetylases related to yeast Hda1p Proc. Natl. Acad. Sci. U. S. A. 96 1999 4868 4873
70. A.R. Guardiola, and T.P. Yao Molecular cloning and characterization of a novel histone deacetylase HDAC10 J. Biol. Chem. 277 2002 3350 3356
71. C. Hubbert HDAC6 is a microtubule-associated deacetylase Nature 417 2002 455 458
72. J. Kovacs HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor Mol. Cell 18 2005 601 607
73. Y. Liu High-throughput assays for sirtuin enzymes: a microfluidic mobility shift assay and a bioluminescence assay Anal. Biochem. 378 2008 53 59
74. B. Heltweg In vitro assays for the determination of histone deacetylase activity Methods 36 2005 332 337
75. K.T. Howitz Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
76. M.T. Borra Mechanism of human SIRT1 activation by resveratrol J. Biol. Chem. 280 2005 17187 17195
77. M. Pacholec SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1 J. Biol. Chem. 285 2010 8340 8351
78. M Kaeberlein Substrate-specific activation of sirtuins by resveratrol J. Biol. Chem. 280 2005 17038 17045
79. L. Blackwell The use of diversity profiling to characterize chemical modulators of the histone deacetylases Life Sci. 82 2008 1050 1058